
New immunotherapy drug frees 43-year-old UK man of deadly brain tumour
New Delhi, July 22 (IANS) A 43-year-old UK man has been declared free from deadly glioblastoma -- the most aggressive and common type of primary brain tumour -- after taking the new immunotherapy drug.Ben Trotman was 40 years old when he was diagnosed with glioblastoma.He became the first patient in the world to participate in a groundbreaking trial of the immunotherapy drug -- ipilimumab -- at the University College London Hospitals (UCLH) in the UK.Trotman received ipilimumab before the standard treatment when the immune system is at its strongest.Following treatment, he underwent the current standard treatment of surgery, radiotherapy, and chemotherapy.More than two and a half years on from treatment, “Trotman is doing well with no active tumour present on scans,” the university said in...









